搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Pseudomonas putida Phosphoribosyl-ATP pyrophosphatase (hisE) CSB-YP538150FGC
CSB-EP538150FGC
CSB-BP538150FGC
CSB-MP538150FGC
CSB-EP538150FGC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida Protein-export protein secB (secB) CSB-YP538151FGC
CSB-EP538151FGC
CSB-BP538151FGC
CSB-MP538151FGC
CSB-EP538151FGC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida S-adenosylmethionine synthase (metK) CSB-YP538152FGC
CSB-EP538152FGC
CSB-BP538152FGC
CSB-MP538152FGC
CSB-EP538152FGC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida Bifunctional protein HldE (hldE) CSB-YP538153FGC
CSB-EP538153FGC
CSB-BP538153FGC
CSB-MP538153FGC
CSB-EP538153FGC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida Homogentisate 1,2-dioxygenase (hmgA) CSB-YP538154FGC
CSB-EP538154FGC
CSB-BP538154FGC
CSB-MP538154FGC
CSB-EP538154FGC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida 1-deoxy-D-xylulose-5-phosphate synthase (dxs), partial CSB-YP538155FGC
CSB-EP538155FGC
CSB-BP538155FGC
CSB-MP538155FGC
CSB-EP538155FGC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida 10 kDa chaperonin (groS) CSB-YP538156FGC
CSB-EP538156FGC
CSB-BP538156FGC
CSB-MP538156FGC
CSB-EP538156FGC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha (accA) CSB-YP538157DSG
CSB-EP538157DSG
CSB-BP538157DSG
CSB-MP538157DSG
CSB-EP538157DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 Serine/threonine-protein kinase pknD (pknD), partial CSB-YP538158DSG
CSB-EP538158DSG
CSB-BP538158DSG
CSB-MP538158DSG
CSB-EP538158DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 50S ribosomal protein L10 (rplJ) CSB-YP538159DSG
CSB-EP538159DSG
CSB-BP538159DSG
CSB-MP538159DSG
CSB-EP538159DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 Exodeoxyribonuclease 7 small subunit (xseB) CSB-YP538160DSG
CSB-EP538160DSG
CSB-BP538160DSG
CSB-MP538160DSG
CSB-EP538160DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 Protein grpE (grpE) CSB-YP538161DSG
CSB-EP538161DSG
CSB-BP538161DSG
CSB-MP538161DSG
CSB-EP538161DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 50S ribosomal protein L21 (rplU) CSB-YP538162DSG
CSB-EP538162DSG
CSB-BP538162DSG
CSB-MP538162DSG
CSB-EP538162DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 Peptide chain release factor 2 (prfB) CSB-YP538163DSG
CSB-EP538163DSG
CSB-BP538163DSG
CSB-MP538163DSG
CSB-EP538163DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 50S ribosomal protein L17 (rplQ) CSB-YP538164DSG
CSB-EP538164DSG
CSB-BP538164DSG
CSB-MP538164DSG
CSB-EP538164DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 30S ribosomal protein S3 (rpsC) CSB-YP538165DSG
CSB-EP538165DSG
CSB-BP538165DSG
CSB-MP538165DSG
CSB-EP538165DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase CSB-YP538166DSG
CSB-EP538166DSG
CSB-BP538166DSG
CSB-MP538166DSG
CSB-EP538166DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 Probable endonuclease 4 (nfo) CSB-YP538167DSG
CSB-EP538167DSG
CSB-BP538167DSG
CSB-MP538167DSG
CSB-EP538167DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 Alanine--tRNA ligase (alaS), partial CSB-YP538168DSG
CSB-EP538168DSG
CSB-BP538168DSG
CSB-MP538168DSG
CSB-EP538168DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis serovar L2 Lysine--tRNA ligase (lysS), partial CSB-YP538169DSG
CSB-EP538169DSG
CSB-BP538169DSG
CSB-MP538169DSG
CSB-EP538169DSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>